Author: Scott Welch
Medicare could have saved nearly $1 billion in 2016 if it used generic versions of pricey combination drug-device products instead of the brand name versions, according to a new study.
More Americans who rely on the Affordable Care Act's exchanges for health insurance coverage are keeping their plans longer throughout the year, which raises questions about what's fueling that trend.
The politics of health care are changing. And one of the most controversial parts of the Affordable Care Act — the so-called Cadillac tax — may be about to change with it.
The latest health insurance data gives new ammunition to the Trump administration as it touts the latest bad news on Obamacare, but supporters of the law say there are positive signs for the state and federal marketplaces as 2019 open enrollment nears.
In a northern California valley stretching under miles of bright blue sky between two snowy volcanic peaks, Mt. Lassen and Mt. Shasta, Daniel Dahle is known as a godsend, a friend, a lifesaver, a companion until the end.
President Trump donated his salary from the second quarter of 2019 to the Surgeon General's office, the White House announced Friday.
California Gov. Gavin Newsom and Attorney General Xavier Becerra on Friday sued to block the Trump administration’s “public charge” rule, which would deny immigrants green cards if they are likely to rely on public benefits.
Soon after news broke last week of the Trump administration’s finalized “public charge” rule, benefit enrollers at the Eisner Health community clinic in downtown Los Angeles started getting phone calls.
Leaning back on a black leather sofa as her campaign bus rumbled toward Fort Dodge, Kamala D. Harris tried to explain why she spent months defending a plan to replace private health insurance with Medicare-for-all, only to switch to a more modest proposal that would allow private insurance to continue after all.
Between 2011 and 2017, Medicare could have saved $17.7 billion if generic versions of older medicines were prescribed instead of updated brand-name drugs launched by drugmakers to replace their older off-patent pills, according to a new study published in the Annals of Internal Medicine.